BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Softic S, Boucher J, Solheim MH, Fujisaka S, Haering MF, Homan EP, Winnay J, Perez-Atayde AR, Kahn CR. Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. Diabetes. 2016;65:2187-2200. [PMID: 27207510 DOI: 10.2337/db16-0213] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Tao C, Wang Y, Zhao Y, Pan J, Fan Y, Liang X, Cao C, Zhao J, Petris MJ, Li K, Wang Y. Adipocyte-specific disruption of ATPase copper transporting α in mice accelerates lipoatrophy. Diabetologia 2019;62:2340-53. [DOI: 10.1007/s00125-019-4966-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Saif M, Kwanten WJ, Carr JA, Chen IX, Posada JM, Srivastava A, Zhang J, Zheng Y, Pinter M, Chatterjee S, Softic S, Kahn CR, van Leyen K, Bruns OT, Jain RK, Bawendi MG. Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin. Nat Biomed Eng 2020;4:801-13. [PMID: 32572196 DOI: 10.1038/s41551-020-0569-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
3 Toyoda S, Shin J, Fukuhara A, Otsuki M, Shimomura I. Transforming growth factor β1 signaling links extracellular matrix remodeling to intracellular lipogenesis upon physiological feeding events. J Biol Chem 2022;298:101748. [PMID: 35189145 DOI: 10.1016/j.jbc.2022.101748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Botezelli JD, Overby P, Lindo L, Wang S, Haïda O, Lim GE, Templeman NM, Pauli JR, Johnson JD. Adipose depot-specific upregulation of Ucp1 or mitochondrial oxidative complex proteins are early consequences of genetic insulin reduction in mice. Am J Physiol Endocrinol Metab 2020;319:E529-39. [PMID: 32715748 DOI: 10.1152/ajpendo.00128.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ayer A, Fazakerley DJ, James DE, Stocker R. The role of mitochondrial reactive oxygen species in insulin resistance. Free Radic Biol Med 2021:S0891-5849(21)00794-2. [PMID: 34775001 DOI: 10.1016/j.freeradbiomed.2021.11.007] [Reference Citation Analysis]
6 Roth SW, Bitterman MD, Birnbaum MJ, Bland ML. Innate Immune Signaling in Drosophila Blocks Insulin Signaling by Uncoupling PI(3,4,5)P3 Production and Akt Activation. Cell Rep 2018;22:2550-6. [PMID: 29514084 DOI: 10.1016/j.celrep.2018.02.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
7 Okuyama T, Shirakawa J, Tajima K, Ino Y, Vethe H, Togashi Y, Kyohara M, Inoue R, Miyashita D, Li J, Goto N, Ichikawa T, Yamasaki S, Ohnuma H, Takayanagi R, Kimura Y, Hirano H, Terauchi Y. Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor. Int J Mol Sci 2020;21:E7815. [PMID: 33105604 DOI: 10.3390/ijms21217815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Yeh YS, Jheng HF, Iwase M, Kim M, Mohri S, Kwon J, Kawarasaki S, Li Y, Takahashi H, Ara T, Nomura W, Kawada T, Goto T. The Mevalonate Pathway Is Indispensable for Adipocyte Survival. iScience 2018;9:175-91. [PMID: 30396151 DOI: 10.1016/j.isci.2018.10.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
9 Mann JP, Semple RK, Armstrong MJ. How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? Front Endocrinol (Lausanne) 2016;7:145. [PMID: 27899914 DOI: 10.3389/fendo.2016.00145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
10 Icli B, Feinberg MW. MicroRNAs in dysfunctional adipose tissue: cardiovascular implications. Cardiovasc Res 2017;113:1024-34. [PMID: 28505257 DOI: 10.1093/cvr/cvx098] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
11 Shin J, Toyoda S, Nishitani S, Onodera T, Fukuda S, Kita S, Fukuhara A, Shimomura I. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1. Metabolism 2022. [DOI: 10.1016/j.metabol.2022.155236] [Reference Citation Analysis]
12 Fourman LT, Lu MT, Lee H, Fitch KV, Hallett TR, Park J, Czerwonka N, Weiss J, Stanley TL, Lo J, Grinspoon SK. Differential relationships of hepatic and epicardial fat to body composition in HIV. Physiol Rep 2017;5:e13386. [PMID: 29038352 DOI: 10.14814/phy2.13386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
13 Hosooka T, Hosokawa Y, Matsugi K, Shinohara M, Senga Y, Tamori Y, Aoki C, Matsui S, Sasaki T, Kitamura T, Kuroda M, Sakaue H, Nomura K, Yoshino K, Nabatame Y, Itoh Y, Yamaguchi K, Hayashi Y, Nakae J, Accili D, Yokomizo T, Seino S, Kasuga M, Ogawa W. The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B4 axis. Proc Natl Acad Sci U S A 2020;117:11674-84. [PMID: 32393635 DOI: 10.1073/pnas.1921015117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lee PL, Jung SM, Guertin DA. The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond. Trends Endocrinol Metab. 2017;28:319-339. [PMID: 28237819 DOI: 10.1016/j.tem.2017.01.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
15 Srinivasan MP, Shawky NM, Kaphalia BS, Thangaraju M, Segar L. Alcohol-induced ketonemia is associated with lowering of blood glucose, downregulation of gluconeogenic genes, and depletion of hepatic glycogen in type 2 diabetic db/db mice. Biochem Pharmacol 2019;160:46-61. [PMID: 30529690 DOI: 10.1016/j.bcp.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Morigny P, Houssier M, Mairal A, Ghilain C, Mouisel E, Benhamed F, Masri B, Recazens E, Denechaud P, Tavernier G, Caspar-bauguil S, Virtue S, Sramkova V, Monbrun L, Mazars A, Zanoun M, Guilmeau S, Barquissau V, Beuzelin D, Bonnel S, Marques M, Monge-roffarello B, Lefort C, Fielding B, Sulpice T, Astrup A, Payrastre B, Bertrand-michel J, Meugnier E, Ligat L, Lopez F, Guillou H, Ling C, Holm C, Rabasa-lhoret R, Saris WHM, Stich V, Arner P, Rydén M, Moro C, Viguerie N, Harms M, Hallén S, Vidal-puig A, Vidal H, Postic C, Langin D. Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity. Nat Metab 2019;1:133-46. [DOI: 10.1038/s42255-018-0007-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
17 Merry TL, Kuhlow D, Laube B, Pöhlmann D, Pfeiffer AFH, Kahn CR, Ristow M, Zarse K. Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan. Aging Cell 2017;16:761-72. [PMID: 28544360 DOI: 10.1111/acel.12610] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
18 Kubota T, Kubota N, Kadowaki T. Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway. Cell Metab. 2017;25:797-810. [PMID: 28380373 DOI: 10.1016/j.cmet.2017.03.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 13.8] [Reference Citation Analysis]
19 Helsley RN, Moreau F, Gupta MK, Radulescu A, DeBosch B, Softic S. Tissue-Specific Fructose Metabolism in Obesity and Diabetes. Curr Diab Rep 2020;20:64. [PMID: 33057854 DOI: 10.1007/s11892-020-01342-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Gao H, Guo Y, Yan Q, Yang W, Li R, Lin S, Bai X, Liu C, Chen D, Cao H, Xiao G. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2. JCI Insight 2019;4:128405. [PMID: 31292295 DOI: 10.1172/jci.insight.128405] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
21 Kineman RD, Del Rio-Moreno M, Sarmento-Cabral A. 40 YEARS of IGF1: Understanding the tissue-specific roles of IGF1/IGF1R in regulating metabolism using the Cre/loxP system. J Mol Endocrinol 2018;61:T187-98. [PMID: 29743295 DOI: 10.1530/JME-18-0076] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
22 Templeman NM, Skovsø S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol 2017;232:R173-83. [PMID: 28052999 DOI: 10.1530/JOE-16-0449] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
23 Carpéné C, Garcia-Vicente S, Serrano M, Marti L, Belles C, Royo M, Galitzky J, Zorzano A, Testar X. Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells. World J Diabetes 2017; 8(4): 143-153 [PMID: 28465791 DOI: 10.4239/wjd.v8.i4.143] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
24 Softic S, Gupta MK, Wang GX, Fujisaka S, O'Neill BT, Rao TN, Willoughby J, Harbison C, Fitzgerald K, Ilkayeva O, Newgard CB, Cohen DE, Kahn CR. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J Clin Invest 2017;127:4059-74. [PMID: 28972537 DOI: 10.1172/JCI94585] [Cited by in Crossref: 124] [Cited by in F6Publishing: 75] [Article Influence: 24.8] [Reference Citation Analysis]
25 Li ME, Lauritzen HPMM, O'Neill BT, Wang CH, Cai W, Brandao BB, Sakaguchi M, Tao R, Hirshman MF, Softic S, Kahn CR. Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism. Nat Commun 2019;10:3412. [PMID: 31363081 DOI: 10.1038/s41467-019-11265-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
26 Beaupere C, Liboz A, Fève B, Blondeau B, Guillemain G. Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance. Int J Mol Sci 2021;22:E623. [PMID: 33435513 DOI: 10.3390/ijms22020623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Homan EP, Brandão BB, Softic S, El Ouaamari A, O'Neill BT, Kulkarni RN, Kim JK, Kahn CR. Differential roles of FOXO transcription factors on insulin action in brown and white adipose tissue. J Clin Invest 2021;131:e143328. [PMID: 34428182 DOI: 10.1172/JCI143328] [Reference Citation Analysis]
28 Szablewski L. From obesity through immunity to type 2 diabetes mellitus. Int J Diabetes Dev Ctries 2017;37:407-18. [DOI: 10.1007/s13410-016-0531-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66:1138-53. [PMID: 28314735 DOI: 10.1136/gutjnl-2017-313884] [Cited by in Crossref: 511] [Cited by in F6Publishing: 449] [Article Influence: 102.2] [Reference Citation Analysis]
30 Morigny P, Langin D. [An unexpected partnership in fat cells: hormone-sensitive lipase and the transcription factor ChREBP jointly control insulin-sensitivity]. Med Sci (Paris) 2019;35:501-3. [PMID: 31274075 DOI: 10.1051/medsci/2019107] [Reference Citation Analysis]
31 Cox AR, Chernis N, Kim KH, Masschelin PM, Saha PK, Briley SM, Sharp R, Li X, Felix JB, Sun Z, Moore DD, Pangas SA, Hartig SM. Ube2i deletion in adipocytes causes lipoatrophy in mice. Mol Metab 2021;48:101221. [PMID: 33771728 DOI: 10.1016/j.molmet.2021.101221] [Reference Citation Analysis]
32 Xia B, Cai GH, Yang H, Wang SP, Mitchell GA, Wu JW. Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice. PLoS Genet 2017;13:e1007110. [PMID: 29232702 DOI: 10.1371/journal.pgen.1007110] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
33 Cao C, Duan P, Li W, Guo Y, Zhang J, Gui Y, Yuan S. Lack of miR-379/miR-544 Cluster Resists High-Fat Diet-Induced Obesity and Prevents Hepatic Triglyceride Accumulation in Mice. Front Cell Dev Biol 2021;9:720900. [PMID: 34527673 DOI: 10.3389/fcell.2021.720900] [Reference Citation Analysis]
34 Damen MSMA, Stankiewicz TE, Park SH, Helsley RN, Chan CC, Moreno-Fernandez ME, Doll JR, Szabo S, Herbert DR, Softic S, Divanovic S. Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae. Int J Obes (Lond) 2021. [PMID: 34302121 DOI: 10.1038/s41366-021-00902-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018;98:2133-2223. [PMID: 30067154 DOI: 10.1152/physrev.00063.2017] [Cited by in Crossref: 475] [Cited by in F6Publishing: 455] [Article Influence: 158.3] [Reference Citation Analysis]
36 Czech MP. Mechanisms of insulin resistance related to white, beige, and brown adipocytes. Mol Metab. 2020;34:27-42. [PMID: 32180558 DOI: 10.1016/j.molmet.2019.12.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
37 Rebelos E, Iozzo P, Guzzardi MA, Brunetto MR, Bonino F. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. World J Gastroenterol 2021; 27(30): 4999-5018 [PMID: 34497431 DOI: 10.3748/wjg.v27.i30.4999] [Reference Citation Analysis]
38 Tilg H, Adolph TE, Moschen AR. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology 2021;73:833-42. [PMID: 32780879 DOI: 10.1002/hep.31518] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 74.0] [Reference Citation Analysis]
39 Stranahan AM. Visceral adiposity, inflammation, and hippocampal function in obesity. Neuropharmacology 2021;205:108920. [PMID: 34902347 DOI: 10.1016/j.neuropharm.2021.108920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes Metab J 2021;45:285-311. [PMID: 33775061 DOI: 10.4093/dmj.2020.0250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
41 Polyzos SA, Perakakis N, Mantzoros CS. Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement. Metabolism 2019;96:66-82. [PMID: 31071311 DOI: 10.1016/j.metabol.2019.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
42 Santoleri D, Titchenell PM. Resolving the Paradox of Hepatic Insulin Resistance. Cell Mol Gastroenterol Hepatol 2019;7:447-56. [PMID: 30739869 DOI: 10.1016/j.jcmgh.2018.10.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
43 Mooring M, Fowl BH, Lum SZC, Liu Y, Yao K, Softic S, Kirchner R, Bernstein A, Singhi AD, Jay DG, Kahn CR, Camargo FD, Yimlamai D. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis. Hepatology 2020;71:1813-30. [PMID: 31505040 DOI: 10.1002/hep.30928] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
44 Cignarelli A, Genchi VA, Perrini S, Natalicchio A, Laviola L, Giorgino F. Insulin and Insulin Receptors in Adipose Tissue Development. Int J Mol Sci 2019;20:E759. [PMID: 30754657 DOI: 10.3390/ijms20030759] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
45 Rodriguez R, Lee AY, Godoy-Lugo JA, Martinez B, Ohsaki H, Nakano D, Parkes DG, Nishiyama A, Vázquez-Medina JP, Ortiz RM. Chronic AT1 blockade improves hyperglycemia by decreasing adipocyte inflammation and decreasing hepatic PCK1 and G6PC1 expression in obese rats. Am J Physiol Endocrinol Metab 2021;321:E714-27. [PMID: 34658252 DOI: 10.1152/ajpendo.00584.2020] [Reference Citation Analysis]
46 Merry TL, Hedges CP, Masson SW, Laube B, Pöhlmann D, Wueest S, Walsh ME, Arnold M, Langhans W, Konrad D, Zarse K, Ristow M. Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease. Nat Commun 2020;11:2080. [PMID: 32350271 DOI: 10.1038/s41467-020-15623-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Softic S, Meyer JG, Wang GX, Gupta MK, Batista TM, Lauritzen HPMM, Fujisaka S, Serra D, Herrero L, Willoughby J, Fitzgerald K, Ilkayeva O, Newgard CB, Gibson BW, Schilling B, Cohen DE, Kahn CR. Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins. Cell Metab 2019;30:735-753.e4. [PMID: 31577934 DOI: 10.1016/j.cmet.2019.09.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 25.0] [Reference Citation Analysis]
48 Straub LG, Efthymiou V, Grandl G, Balaz M, Challa TD, Truscello L, Horvath C, Moser C, Rachamin Y, Arnold M, Sun W, Modica S, Wolfrum C. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity. Diabetologia 2019;62:2094-105. [PMID: 31309261 DOI: 10.1007/s00125-019-4937-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
49 White MF, Kahn CR. Insulin action at a molecular level - 100 years of progress. Mol Metab 2021;:101304. [PMID: 34274528 DOI: 10.1016/j.molmet.2021.101304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Boucher J, Softic S, El Ouaamari A, Krumpoch MT, Kleinridders A, Kulkarni RN, O'Neill BT, Kahn CR. Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function. Diabetes. 2016;65:2201-2213. [PMID: 27207537 DOI: 10.2337/db16-0212] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
51 Ku T, Zhou M, Hou Y, Xie Y, Li G, Sang N. Tebuconazole induces liver injury coupled with ROS-mediated hepatic metabolism disorder. Ecotoxicol Environ Saf 2021;220:112309. [PMID: 34015629 DOI: 10.1016/j.ecoenv.2021.112309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Radulescu A, Killian M, Kang Q, Yuan Q, Softic S. Dietary Counseling Aimed at Reducing Sugar Intake Yields the Greatest Improvement in Management of Weight and Metabolic Dysfunction in Children with Obesity. Nutrients 2022;14:1500. [DOI: 10.3390/nu14071500] [Reference Citation Analysis]
53 Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci 2021;22:4156. [PMID: 33923817 DOI: 10.3390/ijms22084156] [Reference Citation Analysis]
54 Page MM, Johnson JD. Mild Suppression of Hyperinsulinemia to Treat Obesity and Insulin Resistance. Trends in Endocrinology & Metabolism 2018;29:389-99. [DOI: 10.1016/j.tem.2018.03.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
55 Stanford SM, Collins M, Diaz MA, Holmes ZJ, Gries P, Bliss MR, Lodi A, Zhang V, Tiziani S, Bottini N. The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy. J Cell Physiol 2021;236:6630-42. [PMID: 33615467 DOI: 10.1002/jcp.30307] [Reference Citation Analysis]
56 Vázquez-Borrego MC, Del Rio-Moreno M, Kineman RD. Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism. Cells 2021;10:2532. [PMID: 34685512 DOI: 10.3390/cells10102532] [Reference Citation Analysis]
57 Li AA, Ahmed A, Kim D. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Gut Liver. 2020;14:168-178. [PMID: 31195434 DOI: 10.5009/gnl19069] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
58 Arcidiacono B, Chiefari E, Foryst-Ludwig A, Currò G, Navarra G, Brunetti FS, Mirabelli M, Corigliano DM, Kintscher U, Britti D, Mollace V, Foti DP, Goldfine ID, Brunetti A. Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance.EBioMedicine. 2020;59:102912. [PMID: 32739259 DOI: 10.1016/j.ebiom.2020.102912] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
59 Page MM, Skovsø S, Cen H, Chiu AP, Dionne DA, Hutchinson DF, Lim GE, Szabat M, Flibotte S, Sinha S, Nislow C, Rodrigues B, Johnson JD. Reducing insulin via conditional partial gene ablation in adults reverses diet-induced weight gain. FASEB J 2018;32:1196-206. [PMID: 29122848 DOI: 10.1096/fj.201700518R] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
60 Geisler CE, Renquist BJ. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 2017;234:R1-R21. [PMID: 28428362 DOI: 10.1530/joe-16-0513] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 11.6] [Reference Citation Analysis]
61 Softic S, Stanhope KL, Boucher J, Divanovic S, Lanaspa MA, Johnson RJ, Kahn CR. Fructose and hepatic insulin resistance. Crit Rev Clin Lab Sci. 2020;57:308-322. [PMID: 31935149 DOI: 10.1080/10408363.2019.1711360] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
62 Xiong Y, Xu Z, Wang Y, Kuang S, Shan T. Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance. J Lipid Res 2018;59:974-81. [PMID: 29636366 DOI: 10.1194/jlr.M081463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
63 Diwekar-Joshi M, Watve M. Driver versus navigator causation in biology: the case of insulin and fasting glucose. PeerJ 2020;8:e10396. [PMID: 33365205 DOI: 10.7717/peerj.10396] [Reference Citation Analysis]